Board of Directors

Alan C. Nelson, PhD – Chairman of the Board

Dr. Nelson, is founder, chairman and CEO of VisionGate®. He is a physicist, bioengineer and entrepreneur who developed the world’s first and only automated screening test to detect cervical cancer, marketed today as FocalPoint by Becton Dickinson. He is former Executive Director of Arizona State University’s (ASU) Biodesign Institute and has held faculty positions at ASU, University of Washington, MIT and Harvard. Dr. Nelson holds more than 100 US patents and has more than 100 peer-reviewed publications in the field of biomedical imaging.

Terry Fetterhoff, MS Immunology

Mr Fetterhoff began his employment at the Denver Children’s Hospital in 1982. The laboratory later became a reference laboratory for the College of American Pathologists in clinical flow cytometry using the home-build cytometer.  He went on to join Boehringer Mannheim in 1987 to begin a program in flow cytometry reagent development. He was serving as Head of North American R&D when Boehringer Mannheim was acquired by Roche in 1998.  Mr. Fetterhoff then established an R&D facility in Berkeley, CA focused on developing reagents for gene expression and transfection.   In 2001, he joined the Chief Technology Office for Roche Diagnostics where he was responsible for the assessment of novel technologies in medical diagnostics.  Shortly thereafter, he became Head of the US Chief Technology Office where his team was responsible for technology trend analysis and scouting. Since then, Terry has initiated multiple technology acquisitions by Roche Diagnostics, including 454 Life Sciences for DNA sequencing, Iquum for Point of Care molecular diagnostics, and Apprise Bio for sequencing based cellular analysis.  He continues to serve as Head of the US Chief Technology Office and is expected to retire in late 2020.

Greg Zick, PhD Biomedical Engineering

Dr. Zick has over 30 years of experience in computer applications to medicine, computer systems, software development, National Science Foundation (NSF), and National Institute of Health (NIH) funded research projects. During his tenure as a faculty member of the University of Washington, he was awarded six patents, had multiple peer reviewed publications and was chairman of the Electrical and Computer Engineering Department. Dr. Zick left the University of Washington initially to lead a successful startup company and subsequently engineering and product teams in the design and development of multiple successful products and information systems.

This website may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and made in reliance on the "safe harbor" provisions of said act. Forward-looking statements are based on estimates, projections, beliefs and assumptions of VisionGate® management at the time of such statements and are not guarantees of future performance. Forward-looking statements involve risks and uncertainties in predicting future results and conditions. Actual results could differ materially from those projected in these forward-looking statements due to a variety of factors, including, without limitation, the acceptance by customers of our products, our ability to develop new products cost-effectively, our ability to raise capital in the future, the development by competitors of products using improved or alternative technology, the retention of key employees and general economic conditions. Forward-looking statements are subject to change without notice.

Contact Us

If you are interested in learning more about VisionGate and would like to speak with someone, please complete this short inquiry form and a representative will contact you as soon as possible.

Copyright 2021 - VisionGate, Inc.